Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

    ... high risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are commonly older with multiple co-morbidities, ...

    Research Article last updated 05/22/2017 - 11:42am.

  2. Drug reduces acute GVHD in unrelated HSCTs

    ... Article Link:  Vorinostat Lowers Acute GVHD in Patients Receiving Unrelated Donor HSCT ... not an easy population. Most of our patients had acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS), and these are ...

    Article last updated 02/27/2017 - 1:45pm.

  3. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016

    ... blood cytopenias and, sometimes, progression to acute myelogenous leukemia . Research efforts have been made all over the world to ...

    Research Article last updated 01/24/2017 - 11:54am.

  4. Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

    ... Therapy-related myelodysplastic syndromes and acute myelogenous leukemia (t-MDS/AML) comprise a poor-risk subset of MDS/AML. ...

    Research Article last updated 02/04/2013 - 2:39pm.

  5. Molecular Testing in Patients with Suspected Myelodysplastic Syndromes

    ... and with a propensity to transform to acute myelogenous leukemia . Newer technologies such as next-generation sequencing have ...

    Research Article last updated 11/02/2016 - 10:09am.

  6. Top expert calls future MDS/AML care “promising”

    ... paradigms for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), researchers predict that hypomethylating agents, ... diseases—myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). I focused more on MDS because it’s my primary ...

    Article last updated 11/02/2016 - 11:28am.

  7. Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes

    ... has clinical activity in relapsed or refractory acute myelogenous leukemia (AML) and higher-risk myelodysplastic syndromes ...

    Research Article last updated 03/02/2015 - 2:19pm.

  8. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

    ... Therapy-related myelodysplastic syndromes and acute myelogenous leukemia (t-MDS/AML) comprise an increasingly common, poor-risk ...

    Research Article last updated 02/04/2013 - 2:51pm.

  9. Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up

    ... patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) until treatment failure. However, the outcomes for patients who ...

    Research Article last updated 05/26/2015 - 12:53pm.

  10. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myeloid leukemia following aplastic anemia

    ... Secondary myelodysplastic syndrome and acute myelogenous leukemia (sMDS/sAML) are the most serious secondary events ...

    Research Article last updated 01/07/2014 - 12:37pm.